Description

Joel Riley is an assistant professor at the Medical University of Innsbruck, Austria. Joel obtained a BSc in Molecular Medicine from Queen’s University Belfast, UK in 2010. After this he pursued a PhD at the Johnston Cancer Research Centre at Queen’s University Belfast working on the anti-apoptotic protein cFLIP, which he was awarded in 2014.
Following his PhD he moved to the Cancer Research UK Scotland Institute, University of Glasgow to work on mitochondrial cell death.
In 2022 he started his independent group in the Institute of Developmental Immunology at the Medical University of Innsbruck, Austria. His lab continues to work on the cellular, molecular and organismal mechanisms of cell death, with a particular focus on what happens when cell death pathways fail or become dysregulated, and how this can trigger alternative outcomes such as tumour development and activation of immune responses. The lab uses multiple cutting-edge approaches, such as super-resolution imaging, to answer these questions.